Health News Roundup: Germany's confirmed coronavirus cases rise by 1,176 to 253,474; Australia not worried about vaccine trial pause and more
AstraZeneca puts leading COVID-19 vaccine trial on hold over safety concern AstraZeneca Plc on Tuesday said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine because of an unexplained illness in a study participant.Devdiscourse News Desk | Updated: 09-09-2020 11:06 IST | Created: 09-09-2020 10:28 IST
Following is a summary of current health news briefs.
Nine leading U.S. and European vaccine developers pledged on Tuesday to uphold the scientific standards their experimental immunisations will be held against in the global race to contain the coronavirus pandemic. The companies, including Pfizer , GlaxoSmithKline and AstraZeneca, issued what they called a "historic pledge" after a rise in concern that safety and efficacy standards might slip in the rush to find a vaccine.
New York state may move colleges with COVID-19 spikes to remote learning: Cuomo
New York will require kindergarten through 12th grade schools to disclose the number of students and staff testing positive for COVID-19 and may force colleges with more than 100 cases to switch to remote learning, Governor Andrew Cuomo said on Tuesday. Cuomo said the regulations would provide a check on the procedures put in place by colleges and give parents transparency about testing at elementary through high schools.
Qiagen readies launch of rapid COVID-19 antigen test
German diagnostic test maker Qiagen on Tuesday said it planned to launch a COVID-19 antigen test that can provide results in 15 minutes and test about 30 samples in an hour. The company said it will launch two versions of the antigen test, one for labs and one for use at point-of-care use, such as at airports or stadiums, depending on regulatory clearance.
Brazil eyes coronavirus vaccine rollout in January, acting health minister says
Brazil's acting Health Minister Eduardo Pazuello said on Tuesday that a COVID-19 vaccine would be rolled out for all Brazilians in January 2021. "We are closing contracts with vaccine manufacturers and the forecast is that a vaccine will arrive for us starting in January next year and we will start vaccinating everyone," Eduardo Pazuello said in a video posted to social media.
AstraZeneca puts leading COVID-19 vaccine trial on hold over safety concern
AstraZeneca Plc on Tuesday said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine because of an unexplained illness in a study participant. The vaccine, developed with the University of Oxford, has been widely seen as one of the leading global candidates against the coronavirus, and the suspension of the trial dims prospects for a potential year-end rollout its lead developer had signaled earlier.
COVID-19 cases rise in U.S. Midwest and Northeast, deaths fall for third week
Several states in the U.S. Midwest and Northeast have seen new COVID-19 cases increase for two weeks in a row, though nationally both new infections and deaths last week remained on a downward trend, a Reuters analysis showed. The United States reported more than 287,000 new cases in the week ended Sept. 6, down 1.4% from the previous week and marking the seventh straight week of declines. More than 5,800 people died from COVID-19 last week, the third week in a row that the death rate has fallen.
Australia not worried about vaccine trial pause, cases rise in hot spot
Australia is not worried about AstraZeneca Plc's decision to put on hold its COVID-19 vaccine trial, its deputy chief medical officer said on Wednesday, as daily cases nudged higher in the country's coronavirus hot spot. AstraZeneca on Tuesday said it has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after an unexplained illness in a study participant.
Germany's confirmed coronavirus cases rise by 1,176 to 253,474: RKI
The number of confirmed coronavirus cases in Germany increased by 1,176 to 253,474, data from the Robert Koch Institute (RKI) for infectious diseases showed on Wednesday. The reported death toll rose by nine to 9,338, the tally showed.
Venezuelan President Nicolas Maduro on Tuesday proposed administering a Russian coronavirus vaccine to nearly 15,000 candidates in upcoming legislative elections so that they can campaign safely. Russia in August licensed a COVID-19 vaccine after less than two months of human testing, a move celebrated by Moscow but questioned by some experts who note that only about 10% of clinical trials are successful.
England to set tough new socialising rules after virus spike
Tough new lockdown restrictions on social gatherings across the whole of England are to be announced on Wednesday as Prime Minister Boris Johnson tries to control a spike in COVID-19 infections. From Sept. 14, groups of more than six people will be banned from meeting and fined if they fail to comply, Johnson will say.